Analystreport

Proteon Therapeutics Inc (NASDAQ: PRTO) had its "buy" rating re-affirmed by analysts at Brookline Cap M.

PROTEON THERAPEUTICS  (PRTO) 
Last proteon therapeutics earnings: 8/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.proteontherapeutics.com